A comparative analysis of the efficacy of moxifloxacin and cefixime in the reduction of postoperative inflammatory sequelae after mandibular third molar surgery
Abstract
Background/Aim. There is no scientific evidence that the prophylactic use of antibiotics as a part of the mandibular third molar surgery is effective in suppressing postoperative pain, edema, trismus, and dry socket. The aim of the study was to investigate the effects of antibiotics from the fluoroquinolone (moxifloxacin) and cephalosporin (cefixime) groups in reducing postoperative inflammatory sequelae (pain, edema, and trismus), as well as in possibly reducing the incidence of dry socket after mandibular third molar surgery. Methods. This double-blind study was completed by 157 subjects, comprising two study groups (who received the aforementioned antibiotics) and a control group, who received placebo tablets. Subjects were assessed on the first, second, and seventh day following surgery. In the postoperative course, patients were monitored for the occurrence, intensity, and duration of postoperative inflammatory sequelae and dry socket. Results. Both antibiotics, especially moxifloxacin, had a pronounced effect on reducing all inflammatory sequelae (pain, edema, and trismus) as the most common postoperative complaints following mandibular third molar surgery, and also contributed to reducing the incidence of dry socket. Conclusion. Antibiotic prophylaxis with cefixime and, especially moxifloxacin, reduced the occurrence of postoperative inflammatory sequelae and alleviated discomfort. It is interesting, that both antibiotics, especially moxifloxacin, also contributed to reducing the incidence of postoperative dry socket, which is not provoked by inflammation. Therefore, further research into the underlying mechanisms behind such an effect is warranted.
References
Hupp JR. Principles of Management of Impacted Teeth. In: Hupp JR, Tucker MR, Ellis E, editors. Contemporary Oral and Maxillofacial Surgery. Part II: Principles of Exodontia. 7th ed. St. Louis: Mosby-Elsevier; 2018. p. 161‒83.
Martin MV, Kanatas AN, Hardy P. Antibiotic prophylaxis and third molar surgery. Br Dent J 2005; 198(6): 327‒30.
Löffler C, Böhmer F, Hornung A, Lang H, Burmeister U, Podbiel-ski A, et al. Dental care resistance prevention and antibiotic prescribing modification-the cluster-randomised controlled DREAM trial. Implement Sci 2014; 9: 27.
Oliveira AS, Guerreiro MP. Influences on antibiotic prescribing by dentists: Insights from a pilot study. Int J Clin Pharm 2015; 37(1): 180.
Cope AL, Chestnutt IG, Wood F, Francis NA. Dental consulta-tions in UK general practice and antibiotic prescribing rates: A retrospective cohort study. Br J Gen Pract 2016; 66(646): e329‒36.
Arteagoitia MI, Ramos E, Santamaría G, Álvarez J, Barbier L, Santamaría J. Survey of Spanish dentists on the prescription of antibiotics and antiseptics in surgery for impacted lower third molars. Med Oral Patol Oral Cir Bucal 2016; 21(1): e82‒7.
Moloney J, Stassen LF. Pericoronitis: treatment and a clinical dilemma. J Ir Dent Assoc 2009; 55(4): 190‒2.
Rodrigues WC, Okamoto R, Pellizzer EP, dos Carrijo AC, de Al-meida RS, de Melo WM. Antibiotic prophylaxis for third molar extraction in healthy patients: Current scientific evidence. Quintessence Int 2015; 46(2): 149‒61.
Moreno-Drada JA, García-Perdomo HA. Effectiveness of Anti-microbial Prophylaxis in Preventing the Spread of Infection as a Result of Oral Procedures: A Systematic Review and Meta-Analysis. J Oral Maxillofac Surg 2016; 74(7): 1313‒21.
Arteagoitia I, Diez A, Barbier L, Santamaría G, Santamaría J. Ef-ficacy of amoxicillin/clavulanic acid in preventing infectious and inflammatory complications following impacted mandibu-lar third molar extraction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100(1): e11‒8.
Halpern LR, Dodson TB. Does prophylactic administration of systemic antibiotics prevent postoperative inflammatory com-plications after third molar surgery? J Oral Maxillofac Surg 2007; 65(2): 177‒85.
López-Cedrún JL, Pijoan JI, Fernández S, Santamaria J, Hernandez G. Efficacy of amoxicillin treatment in preventing postopera-tive complications in patients undergoing third molar surgery: a prospective, randomized, double-blind controlled study. J Oral Maxillofac Surg 2011; 69(6): e5‒14.
Marcussen KB, Laulund AS, Jørgensen HL, Pinholt EM. A Sys-tematic Review on Effect of Single-Dose Preoperative Anti-biotics at Surgical Osteotomy Extraction of Lower Third Mo-lars. J Oral Maxillofac Surg 2016; 74(4): 693‒703.
Kaczmarzyk T, Wichlinski J, Stypulkowska J, Zaleska M, Panas M, Woron J. Single-dose and multi-dose clindamycin therapy fails to demonstrate efficacy in preventing infectious and inflam-matory complications in third molar surgery. Int J Oral Maxil-lofac Surg 2007; 36(5): 417‒22.
Prajapati A, Prajapati A, Sathaye S. Benefits of not Prescribing Prophylactic Antibiotics After Third Molar Surgery. J Maxillo-fac Oral Surg 2016; 15(2): 217‒20.
Xue P, Wang J, Wu B, Ma Y, Wu F, Hou R. Efficacy of antibi-otic prophylaxis on postoperative inflammatory complications in Chinese patients having impacted mandibular third molars removed: a split-mouth, double-blind, self-controlled, clinical trial. Br J Oral Maxillofac Surg 2015; 53(5): 416‒20.
Sidana S, Mistry Y, Gandevivala A, Motwani N. Evaluation of the need for antibiotic prophylaxis during routine intra-alveolar dental extractions in healthy patients: A Randomized double-blind controlled trial. J Evid Based Dent Pract 2017; 17(3): 184‒9.
Arteagoitia I, Ramos E, Santamaria G, Barbier L, Alvarez J, San-tamaria J. Amoxicillin/clavulanic acid 2000/125 mg to pre-vent complications due to infection following completely bone-impacted lower third molar removal: a clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2015; 119(1): 8‒16.
Oomens MA, Forouzanfar T. Antibiotic prophylaxis in third mo-lar surgery: a review. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 114(6): e5‒12.
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336(7650): 924‒6.
Moreira MR, Carneiro RP, Freire DR, Guimaraes T, Batista de Melo GG. Antimicrobial Modulator of Inflammatory Response in Third Molar Surgery Compared with Conventional Medica-tion. J Res Dent 2019; 7(5): 83‒6.
Dalhoff A. Immunomodulatory activities of fluoroquinolones. Infection 2005; 33 Suppl 2: 55‒70.
Carrillo JS, Calatayud J, Manso FJ, Barberia E, Martinez JM, Do-nado M. A randomized double-blind clinical trial on the effec-tiveness of helium-neon laser in the prevention of pain, swell-ing and trismus after removal of impacted third molars. Int Dent J 1990; 40(1): 31‒6.
Macy E, Romano A, Khan D. Practical Management of Antibi-otic Hypersensitivity in 2017. J Allergy Clin Immunol Pract 2017; 5(3): 577‒86.
Blumenthal KG, Lu N, Zhang Y, Walensky RP, Choi HK. Rec-orded Penicillin Allergy and Risk of Mortality: a Population-Based Matched Cohort Study. J Gen Intern Med 2019; 34(9): 1685‒7.
Chaudhry SB, Veve MP, Wagner JL. Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity. Pharmacy (Basel) 2019; 7(3): 103.
D'Errico S, Frati P, Zanon M, Valentinuz E, Manetti F, Scopetti M, et al. Cephalosporins' Cross-Reactivity and the High De-gree of Required Knowledge. Case Report and Review of the Literature. Antibiotics (Basel) 2020; 9(5): 209.
Limeres J, Sanromán JF, Tomás I, Diz P. Patients' perception of recovery after third molar surgery following postoperative treatment with moxifloxacin versus amoxicillin and clavulanic acid: a randomized, double-blind, controlled study. J Oral Maxillofac Surg 2009; 67(2): 286‒91.
Shahbaz K. Cephalosporins: pharmacology and chemistry. Pharm Biol Eval 2017; 4(6): 234‒8.
Pham TDM, Ziora ZM, Blaskovich MAT. Quinolone antibiotics. Medchemcomm 2019; 10(10): 1719‒39. D
Yuasa H, Kawai T, Sugiura M. Classification of surgical difficul-ty in extracting impacted third molars. Br J Oral Maxillofac Surg 2002; 40(1): 26‒31.
Blondeau F, Daniel NG. Extraction of impacted mandibular third molars: postoperative complications and their risk fac-tors. J Can Dent Assoc 2007; 73(4): 325.
Ndukwe KC, Braimah RO, Owotade JF, Aregbesola SB. Compara-tive Efficacy of Amoxicillin/Clavulanic Acid and Levofloxa-cin in the Reduction of Postsurgical Sequelae After Third Mo-lar Surgery: A Randomized, Double-Blind, Clinical Trial in a Nigerian University Teaching Hospital. Niger J Surg 2016; 22(2): 70‒6.
Siddiqi A, Morkel JA, Zafar S. Antibiotic prophylaxis in third molar surgery: A randomized double-blind placebo-controlled clinical trial using split-mouth technique. Int J Oral Maxillofac Surg 2010; 39(2): 107‒14.
Lacasa JM, Jiménez JA, Ferrás V, Bossom M, Sóla-Morales O, García-Rey C, A, et al. Prophylaxis versus pre-emptive treat-ment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicil-lin/clavulanic acid (1000/62.5 mg). Int J Oral Maxillofac Surg 2007; 36(4): 321‒7.
Monaco G, Tavernese L, Agostini R, Marchetti C. Evaluation of antibiotic prophylaxis in reducing postoperative infection af-ter mandibular third molar extraction in young patients. J Oral Maxillofac Surg 2009; 67(7): 1467‒72.
Bergdahl M, Hedström L. Metronidazole for the prevention of dry socket after removal of partially impacted mandibular third molar: a randomised controlled trial. Br J Oral Maxillo-fac Surg 2004; 42(6): 555‒8.
Noroozi AR, Philbert RF. Modern concepts in understanding and management of the "dry socket" syndrome: comprehen-sive review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107(1): 30‒5.
Euler GJ, Miller GA, Hutter JW, D’Alessandro MM. Interleu-kin-6 in neutrophils from peripheral blood and inflammatory periradicular tissues. J Endod. 1998; 24(7): 480–4.
Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency in-creases inflammatory bone destruction. Infect Immun 2001; 69(2): 744‒50.
Dalhoff A, Shalit I. Immunomodulatory effects of quinolones. Lancet Infect Dis 2003; 3(6): 359‒71.